Results 91 to 100 of about 3,785 (146)

Pitfalls in Valganciclovir Prophylaxis Dose Adjustment Based on Renal Function in Kidney Transplant Recipients

open access: yesTransplant International
Valganciclovir (VGC) is administered as prophylaxis to kidney transplant recipients (KTR) CMV donor (D)+/recipient (R)− and CMV R+ after thymoglobulin-induction (R+/TG).
Nathalie Hammer   +8 more
doaj   +1 more source

Role of oral valganciclovir in sick preterm with cytomegalovirus virus infection and ventilation dependence

open access: yesIndian Journal of Respiratory Care, 2019
Cytomegalovirus (CMV) is the most common congenital viral infection in neonates. Postnatal infection regarding infants rarely has significant clinical consequences. However, preterm may be at higher risk of developing symptomatic postnatal CMV disease. A
Anumodan Gupta   +3 more
doaj   +1 more source

Hidrops fetal por infección congénita por citomegalovirus: tratamiento posneonatal prolongado con valganciclovir

open access: yesRevista Chilena de Obstetricia y Ginecología, 2012
El citomegalovirus (CMV) es la infección viral congénita más frecuente con una prevalencia de 0,5% al nacimiento. La primoinfección aparece entre el 1-4% de las gestantes seronegativas.
Silvia Campos Arca   +5 more
doaj  

Valganciclovir Dosing Strategies for Cytomegalovirus Prophylaxis in Pediatric Solid Organ Transplant Recipients: A Comparative Single-Center Study

open access: yesViruses
Optimal valganciclovir dosing for cytomegalovirus (CMV) prophylaxis in pediatric solid organ transplant recipients remains difficult due to variable pharmacokinetics.
Samar Alharbi   +9 more
doaj   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Cost-utility and budget impact analyses of valganciclovir for cytomegalovirus retinitis in patients with human immunodeficiency virus in Thailand

open access: yesJournal of Pharmaceutical Policy and Practice
Background Cytomegalovirus retinitis (CMVR) is an opportunistic infection frequently seen in people living with HIV (PLHIV) and can cause blindness. Intravenous (IV) ganciclovir is a typical CMVR treatment in Thailand, but oral valganciclovir is a more ...
Tippawan Wongwian   +2 more
doaj   +1 more source

Efficacy of valganciclovir and ganciclovir for cytomegalovirus disease in solid organ transplants: A meta-analysis

open access: yesJournal of Research in Medical Sciences, 2014
Background: Cytomegalovirus (CMV), a problematic virus in solid organ transplant recipients (SOTR) such as liver, can worsen overall mortality and transplant outcome, so its prevention and treatment is a key of success in such patients.
Siavash Vaziri   +6 more
doaj  

Association between White Matter T2 Hyper-Intense Signals in Fetal Brain Magnetic Resonance Imaging and Neurodevelopment of Fetuses with Cytomegalovirus Infection

open access: yesDiagnostics
An association between subtle changes in T2 white matter hyper-intense signals (WMHSs) detected in fetal brain magnetic resonance imaging (fbMRI) and congenital cytomegalovirus (CMV) infection has been established.
Galia Barkai   +5 more
doaj   +1 more source

The pharmacokinetics of valganciclovir prophylaxis in pediatric solid organ transplant patients at risk for Epstein–Barr virus disease

open access: yesClinical Pharmacology: Advances and Applications, 2009
Heather E Vezina1,2, Richard C Brundage2, Thomas E Nevins3, Henry H Balfour Jr1,31Department of Laboratory Medicine and Pathology, 2Department of Experimental and Clinical Pharmacology, 3Department of Pediatrics, University of ...
Heather E Vezina   +3 more
doaj  

Comprehensive insights into cytomegalovirus anterior segment infections: A narrative review

open access: yesTaiwan Journal of Ophthalmology
Cytomegalovirus (CMV) anterior uveitis (AU), a significant cause of intraocular inflammation, is increasingly recognized in immunocompetent individuals, often leading to visual morbidity if not promptly addressed.
Yih-Shiou Hwang   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy